Filing Details

Accession Number:
0001437749-18-010288
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-17 21:18:27
Reporting Period:
2018-05-15
Accepted Time:
2018-05-17 21:18:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434647 Kempharm Inc KMPH Pharmaceutical Preparations (2834) 205894398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1672300 L Daniel Cohen C/O Kempharm, Inc.
2500 Crosspark Road, Suite E126
Coralville IA 52241
Evp, Govt. & Public Relations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-15 5,500 $6.45 35,500 No 4 P Direct
Common Stock Acquisiton 2018-05-15 2,000 $6.45 2,000 No 4 P Direct
Common Stock Acquisiton 2018-05-15 200 $6.45 1,450 No 4 P Indirect By Daughter.
Common Stock Acquisiton 2018-05-15 200 $6.45 1,450 No 4 P Indirect By Daughter.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Indirect By Daughter.
No 4 P Indirect By Daughter.
Footnotes
  1. Held jointly with spouse.
  2. The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares.
  3. The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares.